Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6ADD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $60,734
Award facts
- Contract value 100% obligated
- $60,733.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $60.7 million on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to the Department of Defense Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a continuation of services under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the procurement of pharmaceutical products supporting military healthcare facilities nationwide.
The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its woman-owned small business status. Jakafi (ruxolitinib) is a prescription medication used primarily in the treatment of myelofibrosis and other hematologic conditions. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent performance delivering a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DX25F6ADD?
SPE2DX25F6ADD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 14, 2025.
How much is contract SPE2DX25F6ADD worth?
The government has obligated $60,734 on SPE2DX25F6ADD.
Is contract SPE2DX25F6ADD an order under another contract?
Yes. SPE2DX25F6ADD is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADD competed?
The extent of competition for SPE2DX25F6ADD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award